Tuberous sclerosis: Presentation of a clinical case with oral manifestations;Esclerosis tuberosa: Presentación de un caso clínico con manifestaciones estomatológicas

Medicina Oral

Volumn 8, Issue 2, 2003, Pages 122-128

  López, Edgardo ^a,b   Escovich, Livia ^a,b   Vigna, Alejandro ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b NONE   (Argentina)

Author keywords

Angiofibromas; Bourneville Pringle disease; Neurofibromas; Oral fibromas; Tuberous sclerosis

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; GENE PRODUCT; LOTOKIS; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BEHAVIOR DISORDER; CASE REPORT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 16P; CHROMOSOME 9Q; GENE MUTATION; GENETIC DISORDER; HAMARTOMA; HEMANGIOFIBROMA; HISTOPATHOLOGY; HUMAN; MALE; MENTAL DEFICIENCY; MOUTH DISEASE; NERVE CELL; NEUROFIBROMA; NEUROLOGICAL COMPLICATION; PREVALENCE; SEIZURE; SKIN TUMOR; TSC1 GENE; TSC2 GENE; TUBEROUS SCLEROSIS;

ADULT; FIBROSIS; HUMANS; HYPERPLASIA; MALE; MANDIBULAR DISEASES; MAXILLARY DISEASES; MOUTH DISEASES; TUBEROUS SCLEROSIS;

EID: 19244373313     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bourneville D. Sclereuse tuberese des circonvolutions cerebrales, idiotic et epilepsie hemiplegique. Arch. Neurol 1880;1:81-91.
2. Fleury P, de Groot WP, Delleman JW, Verbeeten B, Frankenmolen-Witkiezwicz IM. Tuberous sclerosis: the incidence of familial versus sporadic cases. Brain Dev 1980;2:107-17.
3. Jones AC, Shymsundar M, Thomas M, Maynard J, Idziaszczyk S, Tomkins S et al. Comprehensive mutation analysis of TSC1 and TSC2, and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64:1305-15.
4. Van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1999;277:805-8.
5. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-15.
6. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Van Slegtenhorst M et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400-6.
7. Soucek T, Pusch O, Wienecke R, De Clue JE, Hengstschlager M. Role of tuberous sclerosis gene-2 product in cell cycle control. J Biol Chem 1997;272:29301-8.
8. Soucek T, Holzl G, Bernaschek G, Hengstschlager M. A role of tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 1998;16:2197-204.
9. Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. Molecular genetic advances in tuberous sclerosis. Hum Genet 2000;107:97-114.
10. Halley DJ. Tuberous sclerosis: between genetic and physical analysis. Acta Genet Med Gemellol 1996;45:63-75.
11. Van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle JP, Snell R, Van den Oweland A et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998;7:1053-7.
12. Young J, Povey S. The genetic basis of tuberous sclerosis. Mol Med Today 1998;4:313-9.
13. Goedbloed MA, Nellist M, Verhaaf B, Reuse AJ, Lindhout D, Sunde L et al. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients. Eur J Hum Genet 2001;9:823-8.
14. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann NY Acad Sci 1991;615:125-7.
15. Davis R, Baer P, Archard H, Palmer J. Tuberous sclerosis epilepsy and family with oral manifestations: report of two cases. Oral Surg 1964;17:395-400.
16. Gorlin R, Chaudhry A, Kelln E. Oral manifestation of the Fitzgerald-Gardner, Pringle-Bourneville, Robin adrenogenital and Hurler-Pfaunder syndromes. Oral Surg 1960;13:1236-44.
17. Scully C. Orofacial manifestation in tuberous sclerosis. Oral Surg 1977;44:706-16.
18. Mackler SB, Shoulars HW, Buker EJ. Tuberous sclerosis with gingival lesions. Oral Surg Oral Med Oral Pathol 1972;34:619-24.
19. Lygidakis NA, Lindenbaum RH. Oral fibromatosis in tuberous sclerosis. Oral Surg Oral Med Oral Pathol 1989;68:725-8.
20. Papanayoyou P, Vezirtzi F. Tuberous sclerosis with gingival lesion. Oral Surg Oral Med Oral Pathol 1975;39:578-82.
21. Butterworth T, Wilson M. Dermatologic aspects of tuberous sclerosis. Arch Dermatol Syph 1941;43:1-41.
22. Good C, Garb J. Symmetric nevi of face, tuberous sclerosis epilepsy and fibromatous growth on scalp with abnormal encephalograms of members of the family. Arch Dermatol Syph 1943;47:197-215.
23. Tillman HH, De Caro F. Tuberous sclerosis. Oral Surg Oral Med Oral Pathol 1991;71:301.
24. Mlynarezyk G. Enamel pitting: a common symptom of tuberous sclerosis. Oral Surg Oral Med Oral Pathol 1991;71:63-7.
25. Durán-Padilla M, Paredes-Farreras G, Torres-González C. Enamel hypoplasia in tuberous sclerosis. Rev Invest Clin 2001;53:126-8.
26. Damm D, Tomich Ch, White D, Drummond J. Intraosseous fibrous lesions of the jaws. A manifestation of tuberous sclerosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:334-40.
27. Roach ES, Gomez MR, Northrup H. Tuberous Sclerosis Complex Consensus Conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-8.
28. Martin J, Longo F. Diagnóstico molecular de los trastornos neurológicos. In: Harrison TR. Principios de Medicina Interna. Madrid, McGraw-Hill. Interamericana Editores; 1998. p. 2608-23.
29. Regezi J, Sciubba J. Patología bucal: correlaciones clinicopatológicas. México. McGraw-Hill. Interamericana Editores; 2000. p. 182-5.